Apparatuses and methods for treating ophthalmic diseases and disorders
AssigneeTissuetech, Inc.
InventorsScheffer TSENG, Ek Kia TAN
Life of this patent
Estimating the term…
Abstract
The invention relates generally to the fields of biology and health sciences. More particularly, the invention relates to compositions and methods for modulating cellular physiology and pathological processing using a combination of compounds that can be found in amniotic membrane tissue and umbilical cord tissue preparations.
Claims95
An apparatus for treating dry eye or other diseases or disorders of the eye, by insertion of the device onto the surface of the eye of a patient in need thereof, wherein the apparatus comprises:
- one or more flexible tubular structures, wherein the one or more flexible tubular structures comprise a material selected from the group consisting of:
- ethylene vinyl acetate (EVA);
- polydimethylsiloxane (PDMS);
- polymethylmetacrylate (PMMA);
- polyethylene teraphthalate (PET);
- polycarbonate (PC);
- hydrogels;
- polyvinyl chloride (PVC);
- rubber;
- latex;
- polyethylene (PE);
- silicone;
- polytetrafluoroethylene (PTFE);
- polyurethane (PU);
- umbilical cord tissue;
- amniotic membrane tissue;
- placental tissue;
- chorion tissue and any combination thereof.
An apparatus for treating dry eye or other diseases or disorders of the eye, by insertion of the apparatus onto the surface of the eye of a patient in need thereof, wherein the apparatus comprises:
- one or more flexible tubular structures, wherein the one or more flexible tubular structures comprise a material selected from the group consisting of:
- ethylene vinyl acetate (EVA);
- polydimethylsiloxane (PDMS);
- polymethylmetacrylate (PMMA);
- polyethylene teraphthalate (PET);
- polycarbonate (PC);
- hydrogels;
- polyvinyl chloride (PVC);
- rubber;
- latex;
- polyethylene (PE);
- silicone;
- polytetrafluoroethylene (PTFE);
- polyurethane (PU);
- umbilical cord tissue;
- amniotic membrane tissue;
- placental tissue;
- chorion tissue and any combination thereof;
- and
- one or more flexible fastening cuffs,
- wherein the inner surface of the one or more flexible fastening cuffs are frictionally engaging the outer surface of the one or more flexible tubular structures.
An apparatus for treating dry eye or other diseases or disorders of the eye, by insertion of the device onto the surface of the eye of a patient in need thereof, wherein the apparatus comprises:
- at least one sheet comprising a material selected from the group consisting of:
- umbilical cord tissue;
- amniotic membrane tissue;
- placental tissue;
- chorion tissue;
- ethylene vinyl acetate (EVA);
- polydimethylsiloxane (PDMS);
- polymethylmetacrylate (PMMA);
- polyethylene teraphthalate (PET);
- fibrins;
- polycarbonate (PC);
- hydrogels;
- polyvinyl chloride (PVC);
- rubber;
- latex;
- polyethylene (PE);
- silicone;
- polytetrafluoroethylene (PTFE);
- polyurethane (PU) and combinations thereof;
- and
- at least one tubular structure comprising a second material selected from the group consisting of:
- umbilical cord tissue;
- amniotic membrane tissue;
- placental tissue;
- chorion tissue;
- ethylene vinyl acetate (EVA);
- polydimethylsiloxane (PDMS);
- polymethylmetacrylate (PMMA);
- polyethylene teraphthalate (PET);
- fibrins;
- polycarbonate (PC);
- hydrogels;
- polyvinyl chloride (PVC);
- rubber;
- latex;
- polyethylene (PE);
- silicone;
- polytetrafluoroethylene (PTFE);
- polyurethane (PU) and combinations thereof,
- wherein at least one sheet and at least one tubular structure are adhering to maintain physical contact with one another.
An apparatus for treating dry eye or other diseases or disorders of the eye, by insertion of the device onto the surface of the eye of a patient in need thereof, wherein the apparatus comprises:
- at least one first sheet comprising a material selected from the group consisting of:
- umbilical cord tissue;
- amniotic membrane tissue;
- placental tissue;
- chorion tissue;
- ethylene vinyl acetate (EVA);
- polydimethylsiloxane (PDMS);
- polymethylmetacrylate (PMMA);
- polyethylene teraphthalate (PET);
- fibrins;
- polycarbonate (PC);
- hydrogels;
- polyvinyl chloride (PVC);
- rubber;
- latex;
- polyethylene (PE);
- silicone;
- polytetrafluoroethylene (PTFE);
- polyurethane (PU) and combinations thereof;
- and
- at least one second sheet comprising a second material selected from the group consisting of:
- umbilical cord tissue;
- amniotic membrane tissue;
- placental tissue;
- chorion tissue;
- ethylene vinyl acetate (EVA);
- polydimethylsiloxane (PDMS);
- polymethylmetacrylate (PMMA);
- polyethylene teraphthalate (PET);
- fibrins;
- polycarbonate (PC);
- hydrogels;
- polyvinyl chloride (PVC);
- rubber;
- latex;
- polyethylene (PE);
- silicone;
- polytetrafluoroethylene (PTFE);
- polyurethane (PU) and combinations thereof,
- wherein the at least one first sheet and the at least one second sheet are adhering to maintain physical contact with one another.
Dependencies are inferred from the claim text.